Trump to select Heidi Overton for FDA commissioner

President Donald Trump will nominate White House health policy official Heidi Overton to lead the Food and Drug Administration, setting up a Senate confirmation process as the agency looks to install permanent leadership after months of transition.

What you’ll learn

• Who Heidi Overton is and how her experience shaping health policy in the Trump administration could inform her approach to leading the FDA
• How Overton’s background in medicine, public health and conservative health policy has positioned her for the nomination
• What her selection could mean for an agency that has faced leadership turnover, layoffs and policy disputes with lawmakers and the pharmaceutical industry

Why this matters

FDA leadership can shape regulatory priorities and decisions with significant implications for drugmakers, health care organizations and other regulated industries. POLITICO Pro helps health care professionals stay ahead of leadership changes and policy developments that could influence regulation, business strategy and the broader health care landscape.

Fill out the form to read the full POLITICO Pro article.